Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '17 aag hydrochloride'

Search results for: '17 aag hydrochloride'

Items 31-40 of 42

Page
per page
  1. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  2. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL
  3. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  4. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
  5. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL
  6. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  7. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  8. Phenformin HCl
    B1373 Phenformin HCl
     1 Citation
    Target: AMPK
    Summary: biguanidine drug with anti-diabetic activity
      ≥12.1 mg/mL
  9. Terbinafine HCl
    B2047 Terbinafine HCl
    Target: Squalene epoxidases
    Summary: Potent non-competitive inhibitor of squalene epoxidase
      insoluble in H2O; ≥16.3 mg/mL
  10. Dexmedetomidine HCl
    B1357 Dexmedetomidine HCl
    Summary: Highly selective and potent alpha-2 adrenoceptor agonist
      ≥126.2 mg/mL

Items 31-40 of 42

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 41item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Proteasome 1 item
  3. Histone Deacetylases (HDACs) 1 item
  4. Raf 1 item
  5. Aurora Kinases 1 item
  6. EZH2 1 item
  7. Bromodomains 1 item
  8. Thymidine Phosphorylases 1 item
  9. VEGFR 1 item
  10. PDGFR 1 item
  11. Phosphodiesterases (PDEs) 1 item
  12. MEK 1 item
  13. FGFR 1 item
  14. Pim 1 item
  15. Sir2-like Family Deacetylases (Sirtuins) 1 item
  16. Deubiquitinating enzymes (DUBs) 1 item
  17. EGFR 1 item
  18. FAK 1 item
  19. Syk 1 item
  20. HSP90 1 item
  21. AMPK 1 item
  22. PKC 1 item
  23. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  24. Pyk2 1 item
  25. 5-HT2 Receptors 2item
  26. S1P receptors 1 item
  27. Myosin light chain kinases (MLCKs) 1 item
  28. 5-HT3 Receptors 1 item
  29. Squalene epoxidases 1 item
  30. Nampt 1 item
  31. Glutamate (Metabotropic) Group I Receptors 1 item
  32. AChE 1 item
  33. HBV Proteases 1 item
  34. IKK 1 item
  35. Calcium-Sensing Receptors (CaSRs) 1 item
  36. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 5item
  5. Cancer 17item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 2item
  9. Colorectal Cancer 4item
  10. Erectile Dysfunction 1 item
  11. Glioblastoma 2item
  12. Glioma 2item
  13. Hepatocellular Carcinoma 1 item
  14. HIV Infections 2item
  15. Inflammatory Diseases 2item
  16. Leukemia 1 item
  17. Lung Cancer 3item
  18. Lymphoma 1 item
  19. Melanoma 2item
  20. Multidrug Resistance Studies 1 item
  21. Multiple Myeloma 4item
  22. Narcolepsy 1 item
  23. Non-small Cell Lung Cancer 2item
  24. Ovarian Cancer 1 item
  25. Pancreatic Cancer 3item
  26. Prostate Cancer 4item
  27. Schizophrenia 1 item
  28. Type 2 Diabetes 1 item